SCHEMBL6788587

SCHEMBL6788587

O=C(NCC(F)(F)F)C1(CCCCN2CCN(c3ccc(Cl)c(C(F)(F)F)c3)CC2)c2ccccc2-c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTTP P55157 5/20 0.53
CHRM2 P08172 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CHRM1 P11229 1/20 0.53
DRD1 P21728 1/20 0.53
TBXA2R P21731 1/20 0.53
PTGS1 P23219 1/20 0.53
SLC6A2 P23975 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
DRD3 P35462 1/20 0.53
SLC6A3 Q01959 1/20 0.53
KCNH2 Q12809 1/20 0.53
MTR Q99707 1/20 0.53
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
HTR7 P34969 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6794488 0.92 MTTP (0.53) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL5863805 0.90 MTTP (0.55) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6795011 0.88 MTTP (0.54) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6792357 0.88 MTTP (0.55) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL5863477 0.88 MTTP (0.52) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6799306 0.86 MTTP (0.60) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6786911 0.86 MTTP (0.58) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6794059 0.86 MTTP (0.66) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6791939 0.86 MTTP (0.52) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL6794169 0.86 MTTP (0.54) MTTPCHRM2ADRA2AADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818644-B1 FLUORENE-9-CARBOXYLIC AMIDES; INHIBITORS OF MICROSOMAL TRIGLYSERIDE-TRANSFER PROTEIN (MTP); ANTILIPEMIC AGENTS; ATHEROSCLEROSIS, DIABETES, EATING DISORDERS, AND PANCREATITIS BOEHRINGER INGELHEIM PHARM GMBH & CO, KG (DE) 2004-11-16 US disclosed